On 30 MAY JD.Com Inc (ADR) (NASDAQ:JD) reported $16.7 billion of annual sales in February 2014, raised $1.8 billion through its IPO listing on the U.S. securities exchange. The company offered 93.7 million shares priced at $19 each. JD.Com Inc (ADR) (NASDAQ:JD) weekly performance is -0.97%. On last trading day company shares ended up $24.54. Analysts mean target price for the company is $24.50. JD.Com Inc (ADR) (NASDAQ:JD) distance from 50-day simple moving average (SMA50) is 3.96%.
NQ Mobile Inc (ADR) (NYSE:NQ) now expects Q1 net revenues to exceed the previously announced revenue guidance range of $75M-$76M, saying saw continued strength in its businesses, in particular in the enterprise segment. “The unaudited first quarter 2014 results will be released as soon as practicable,” NQ Mobile Inc (ADR) (NYSE:NQ) stated. NQ Mobile Inc (ADR) (NYSE:NQ) shares advanced 30.93% in last trading session and ended the day on $9.99. NQ Gross Margin is 63.50% and its return on assets is 2.40%. NQ Mobile Inc (ADR) (NYSE:NQ) quarterly performance is -52.04%.
Micron Technology, Inc. (NASDAQ:MU) outlined the company’s plans for participation in the upcoming 2014 Symposia on VLSI Technology and Circuits scheduled for June 9-13. Along with executive panel appearances, the Micron Research and Development team will feature presentations at the conference on integration of silicon photonics in bulk CMOS and copper resistive random access memory (ReRAM) for storage class memory applications. Micron Technology, Inc. (NASDAQ:MU) shares moved up 1.05% in last trading session and was closed at $28.97, while trading in range of $28.47 – $29.01. Micron Technology, Inc. (NASDAQ:MU) year to date (YTD) performance is 33.20%.
Guggenheim Solar ETF (NYSEARCA: TAN) is up while the Market Vectors Solar Energy ETF is down Year-to-date, Guggenheim Solar ETF (NYSEARCA: TAN) has increased 13.5% and KWT gained 9.7%. Guggenheim Solar ETF (NYSEARCA: TAN) ended the last trading day at $40.13. Company weekly volatility is calculated as 2.89% .Guggenheim Solar ETF (NYSEARCA: TAN) showed a negative weekly performance of -1.45%.
On 2 JUNE Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced that the United States Food and Drug Administration (FDA) has informed the Company that the FDA intends to reassign the Prescription Drug User Fee Act (PDUFA) action date for the NB32 New Drug Application to June 11, 2014, one day beyond the original assignment. The FDA noted that due to an inadvertent administrative error, the Agency had miscalculated the originally assigned PDUFA date. Orexigen Therapeutics, Inc. (NASDAQ:OREX) weekly performance is -2.24%. On last trading day company shares ended up $6.12. Analysts mean target price for the company is $11.86. Orexigen Therapeutics, Inc. (NASDAQ:OREX) distance from 50-day simple moving average (SMA50) is 5.95%.